Sonoma Pharmaceuticals (SNOA) EBT Margin (2020 - 2022)
Sonoma Pharmaceuticals (SNOA) has 3 years of EBT Margin data on record, last reported at 8.72% in Q4 2012.
- For Q4 2012, EBT Margin rose 9378.0% year-over-year to 8.72%; the TTM value through Dec 2012 reached 64.1%, up 220437.0%, while the annual FY2012 figure was 58.02%, 76924.0% up from the prior year.
- EBT Margin reached 8.72% in Q4 2012 per SNOA's latest filing, up from 17.69% in the prior quarter.
- Across five years, EBT Margin topped out at 24.2% in Q1 2011 and bottomed at 1097.72% in Q2 2010.
- Average EBT Margin over 3 years is 208.05%, with a median of 34.46% recorded in 2012.
- The widest YoY moves for EBT Margin: up 89646bps in 2012, down -5867bps in 2012.
- A 3-year view of EBT Margin shows it stood at 89.32% in 2010, then increased by 5bps to 85.05% in 2011, then skyrocketed by 110bps to 8.72% in 2012.
- Per Business Quant database, its latest 3 readings for EBT Margin were 8.72% in Q4 2012, 17.69% in Q3 2012, and 20.49% in Q2 2012.